July 29, 2026
Humana has reaffirmed its expectations that Medicare Advantage membership will grow by 25% this year, the company said Wednesday.
This article was originally published on Fierce Healthcare.
The industry's trusted authority on overturning denials and payer audits — equipping providers with the expertise, resources, and community to challenge unfair practices, recover rightful revenue, and drive lasting change in healthcare reimbursement.
AHDAM speaks for the people doing the work — pushing back on payer practices that erode reimbursement, surfacing patterns across hospitals, and partnering with policy bodies to drive change.
119+ tip sheets, templates, policies, and 50 state-by-state legal snippets — searchable by denial type, payer, and clinical scenario. Two decades of practitioner-tested guidance.
Live sessions and on-demand recordings from the appeal professionals who've done it. Clinical validation. DRG downgrades. Prior auth strategy. Ask-the-experts Q&A built in.
AHDAM Appeal Management Certification — the credential that proves you can do this work. Curriculum, exam, continuing education, all in one pathway.
AHDAM is proud to announce a strategic partnership with Hyve Health. Our shared mission is to strengthen the healthcare community's ability to prevent manage, and overturn insurance denials.
HYVE brings advanced analytics and tranparency tools, like the Payer Vitality Scorecard™, empowering providers to track and respond to shifting payer behavior.
Partners →
PayerWatch is on a mission to ensure every hospital in the U.S. is fully capable of defending themselves against egregious payer behavior. That's a mission we at AHDAM can get behind!
Through sophisticated software and world-class appeal solutions PayerWatch is holding payers accountable and protecting provider revenue like no one else in healthcare today.
Partners →AHDAM is the only place I've found where the appeal letters, the legal precedent, and the people who've actually overturned these denials all live in one room.
I've written hospital appeals for 15 years. By far the most practical training I've ever taken — clinically grounded, legally informed, and immediately useful Monday morning.
The Minnesota ACDIS chapter learned an enormous amount. Conversational, candid, and packed with strategy we can deploy that day.
Founded AHDAM to put practitioner intelligence in every appeal professional's hands. Two decades in healthcare denial & appeal management.
Senior Fellow in Hospital Medicine. Leads clinical & physician-advisor programming, peer-to-peer strategy, and the certification curriculum.
AHDAM's board brings together healthcare attorneys, physician advisors, and revenue cycle leaders from health systems nationwide.
Become a member, get certified, or ask the appeal experts — three ways into the AHDAM community.
July 29, 2026
Humana has reaffirmed its expectations that Medicare Advantage membership will grow by 25% this year, the company said Wednesday.
This article was originally published on Fierce Healthcare.
Author: John K. Hall, MD, JD, MBA, FCLM, FRCPC | July 28, 2026
This article arises, in part, from my Monitor Monday segment on the organizational responses to Aetna’s inpatient payment reduction policy. As a quick review, under the policy, inpatient claims for 1-3 midnight duration are approved as inpatient but subjected to a reduced payment.
As I mentioned this is genius since it avoids the operational consequences of denials while still saving Aetna money on payments. During the segment I outlined several viable responses to Aetna’s predatory practice.
Subsequently I received many questions and comments about the perception that organizations have had such a limited response. Some providers have responded. Others have not. Many providers simply wedged the new payment policy into denial structures. I suspect that a major reason that for limited response is something called “status quo bias.” This phenomenon was first recognized in 1988. We know it by its more colloquial name “inertia.”
In short, status quo bias is the psychological and emotional preference for the current state of affairs resulting in a resistance to change that can paralyze otherwise skilled decision makers. The two best examples are changing your auto insurance and changing your rental storage unit.
Status quo bias is not completely illogical. First the organization must reconcile the need for new training and tachniques associated with a modified strategy. Even if the modified has InoI additional costs it still must be assessed in light of the “sunk costs” associated with current strategies.
Any new costs invoke the possibility of additional losses. Under any extant strategy losses are generally calculable- possibly even manageable. New strategies entail additional costs in an unpredictable fashion. That brings an inherent risk aversion. Organizations, typically assign greater importance to losses than potential gains even in situations where losses and gains are identifiable with relative certainty.
Next is regret avoidance. In those cases where we know the current losses, and the reason for the losses, we generally prefer the status quo to the possibility of a change that may ultimately fail. This plays a prominent role when stakes are high, and the current risks are deemed “acceptable.”
Next is the possibility of two related effects called choice overload and decision avoidance. In the case of responses to Aetna’s payment policy the choices are somewhat limited- certainly not overwhelming. But some responses may have adverse financial implications thereby encouraging decision makers to avoid decisions.
Finally, an organization must be able to accept that a new strategy will yield superior outcomes.
So how can an organization make a change. First, it requires a willingness to make and understand data-driven analyses. Then, the organization must accept the analyses and conclusions. The next step is to develop a logical response including an extensive failure mode analysis. Finally, the change must be operationalized.
I make this sound easy but the two immediate roadblocks are the decision maker and the organizations members. The decision maker must manage cognitive dissonance.
Longer delays related to operational changes lead to greater cognitive dissonance and the likelihood of stagnation.
This article was originally published on RACmonitor.
Author: Penny Jefferson, MSN, RN, CCDS, CCDS-O, CCS, CDIP, CRC, CHDA, CRCR, CPHQ, ACPA-C | July 28, 2026
The fiscal year (FY) 2027 Inpatient Prospective Payment System (IPPS) Proposed Rule suggests that the next phase of value-based care will require hospitals to manage episodes, networks, and outcomes beyond their own walls.
Each year, healthcare leaders review the Centers for Medicare & Medicaid Services (CMS) Inpatient Prospective Payment System rule for changes affecting hospital payment, coding, quality programs, and operations.
That annual review is necessary, but it can also become too narrow.
When organizations evaluate each provision independently, they may miss the larger direction Medicare is signaling. The FY 2027 IPPS Proposed Rule offers an important example.
CMS displayed the proposed rule on April 10, 2026, and published it on April 14, 2026. Among its provisions, CMS proposes expanding the Comprehensive Care for Joint Replacement Model through a new model called the Comprehensive Care for Joint Replacement Expanded Model, or CJR-X. [1]
If finalized, CJR-X would become a mandatory nationwide episode-based payment model beginning Oct. 1, 2027. The proposal focuses on lower-extremity joint replacements, but its strategic significance extends beyond orthopedics.[2]
When considered alongside the mandatory Transforming Episode Accountability Model, or TEAM, CJR-X signals that Medicare is continuing to move hospitals from responsibility for an individual encounter toward accountability for cost, quality, and coordination across a defined episode of care. [2,3]
This is more than another payment methodology.
It represents a different hospital operating model.
Value-based care is not new. Hospitals have participated in accountable care arrangements, bundled-payment initiatives, shared-savings programs, and quality-based reimbursement models for years.
However, voluntary and mandatory participation create different organizational expectations.
Voluntary models may disproportionately attract hospitals that already possess the infrastructure, physician alignment, financial capacity, and analytic sophistication necessary to manage risk. Mandatory models bring a broader range of organizations into the payment transformation, including hospitals that may not have deliberately chosen to assume episode-level accountability.
TEAM is already operating as a mandatory episode-based payment model in selected Core-Based Statistical Areas. The model began Jan. 1, 2026, and will continue through Dec. 31, 2030. Participating acute-care hospitals coordinate care for Original Medicare beneficiaries undergoing one of five surgical episode categories:
TEAM episodes extend from the surgery through 30 days after the patient leaves the hospital.[3]
CJR-X would broaden that direction considerably.
If finalized, most hospitals paid under the IPPS would be required to participate nationwide. Proposed exclusions include hospitals participating in TEAM, hospitals located in Maryland, and hospitals not paid under both the IPPS and the Hospital Outpatient Prospective Payment System. Critical access hospitals and rural emergency hospitals would consequently be excluded. CMS describes CJR-X as the first nationwide test of a mandatory episode-based payment model.[2]
The central signal is not simply that Medicare continues to test value-based care.
The signal is that episode accountability is moving beyond optional experimentation.
Hospital leaders should therefore stop treating bundled payment as a specialized finance initiative that can be activated only when an organization elects to participate. The capabilities necessary to succeed under these models are becoming core operating capabilities.
Hospitals have traditionally organized performance around identifiable events: an admission, an inpatient stay, a procedure, a discharge, or a claim.
Episode-based payment changes the boundaries of accountability.
Under the proposed CJR-X model, an episode would begin with a qualifying hip, knee, or ankle replacement performed in the hospital inpatient or outpatient setting. The episode would continue through the first 90 days of recovery after discharge from the inpatient hospitalization or completion of the outpatient procedure.[2]
With limited exceptions, the target price would account for Medicare costs associated with the lower-extremity joint-replacement episode. Hospitals and other providers would continue to receive fee-for-service payments through existing Medicare payment systems. CMS would later compare actual episode spending with the participating hospital’s target price. Depending on spending and quality performance, the hospital could receive a reconciliation payment or be required to repay Medicare.[2]
This means that a technically successful procedure and an uncomplicated hospitalization may no longer be sufficient to define a successful episode.
A patient may still experience delayed rehabilitation, an avoidable emergency department visit, a medication-related complication, an unnecessary skilled nursing facility stay, fragmented follow-up care, or a preventable readmission.
Those events may occur after the patient has left the hospital, but they can influence the quality, cost, and overall performance of the episode.
Hospitals are not being asked to control every decision made by every clinician or post-acute provider. They are being asked to establish a more reliable care pathway in which avoidable fragmentation can be identified and reduced.
That distinction matters.
Episode accountability is not simply an extension of the hospital stay. It requires hospitals to understand the recovery process as a connected clinical and financial continuum.
Traditional hospital service-line scorecards may include procedural volume, contribution margin, operating-room utilization, length of stay, complications, mortality, and readmissions.
Those measures remain valuable, but they are incomplete when accountability extends for 30 or 90 days beyond discharge.
Under episode-based payment, service-line leaders may also need to understand:
This does not mean that every higher-cost episode represents poor performance.
A medically complex patient may appropriately require additional services. A patient living alone may have different discharge needs than a patient with reliable caregiver support.
Rural patients may face limited access to home health, physical therapy, or skilled nursing care. Functional status, frailty, comorbidities, housing, transportation, and caregiver availability can all influence the recovery pathway.
The leadership challenge is to understand why the variation occurs.
Organizations should be able to distinguish clinically necessary variation from variation caused by inconsistent practice, limited coordination, unnecessary duplication, or unreliable processes.
That requires a different level of service-line integration.
Physician leaders, finance, nursing, case management, rehabilitation, quality, utilization management, and post-acute partners cannot evaluate episode performance from separate departmental perspectives. They need a shared view of the patient journey and a common understanding of where outcomes and spending begin to diverge.
The growing importance of post-acute care may be one of the most consequential signals from Medicare’s episode-based models.
CMS designed TEAM to address fragmented care from surgery through 30 days after hospitalization. CJR-X would similarly hold participating hospitals responsible for helping patients receive coordinated and affordable care from the time of the qualifying procedure through the first 90 days of recovery. [2,3]
Both models emphasize transitions among hospitals, physicians, rehabilitation providers, and other post-acute services.
A hospital may not own the skilled nursing facility, home health agency, outpatient rehabilitation provider, or physician practice delivering the next phase of care. Nevertheless, the cost, quality, timeliness, and coordination of those services may influence the hospital’s episode performance.
Post-acute relationships can therefore no longer be treated solely as discharge-planning resources.
They are becoming part of hospital strategy.
Organizations should understand which providers consistently achieve strong outcomes, where communication delays occur, whether recommended services are available promptly, and which post-acute patterns are associated with avoidable acute-care utilization.
Hospitals should also evaluate whether patients and post-acute providers receive timely and clinically useful information. A discharge summary that arrives after the first post-acute visit, an incomplete medication list, or an unclear follow-up plan can create risks that are not confined to one department or one claim.
At the same time, hospitals must preserve patient choice.
CMS states that beneficiaries receiving care through CJR-X participants would retain their freedom to choose physicians, facilities, and other providers and services.[2] The objective is not to direct every patient into a closed network. It is to improve coordination, provide meaningful information, and help patients navigate the recovery process while respecting their right to select their providers.
This balance will require thoughtful governance. Hospitals will need transparent criteria for evaluating post-acute performance, compliant methods of sharing information with patients, and processes that do not confuse coordination with control.
Episode-based payment can create distinct challenges for rural and safety-net organizations.
A clinically appropriate post-acute service may not be available locally. Transportation barriers, workforce shortages, caregiver limitations, housing instability, and geographic distance may make an otherwise reasonable recovery plan difficult to execute.
Those factors can influence the patient’s use of post-acute care, access to physical therapy, ability to attend follow-up appointments, and risk of returning to the emergency department.
CMS is proposing several protections under CJR-X. These include a five-percent stop-loss limit for hospitals serving a high proportion of patients who are dually eligible for Medicare and Medicaid, geographically rural hospitals, Medicare-dependent small rural hospitals, and sole community hospitals.[2]
CMS is also proposing a more extensive risk-adjustment methodology. CJR-X would use 29 risk adjusters, compared with three in the previous CJR model. The methodology would include hospital-level and patient-level factors such as hospital bed count, age, chronic-condition burden, dual eligibility, procedure type, disability as the original reason for Medicare entitlement, prior post-acute care use, and selected Hierarchical Condition Categories.[2]
These protections acknowledge that hospitals serve different populations and operate within different care environments.
They do not, however, eliminate the need for organizations to understand their own communities, referral patterns, access limitations, and post-acute capacity.
Episode-based payment creates pressure to reduce unnecessary spending. CMS identifies fragmented care, duplicated resources, avoidable utilization, complications, and readmissions as problems that TEAM and CJR-X are intended to address.[2,3]
However, lower spending alone is not the definition of high-value care.
The least expensive discharge destination is not always the most appropriate destination. Fewer services do not necessarily produce a better outcome. A patient who requires skilled rehabilitation should not be denied that level of care merely because discharge home is less costly.
The goal is not indiscriminate utilization reduction.
The goal is to remove services that do not add clinical value while preserving those necessary for safe recovery.
That distinction requires clinical leadership.
Organizations need mechanisms for identifying when variation is supported by patient complexity and when it reflects a process that should be redesigned. Financial data can show where spending differs, but it cannot independently explain whether the difference was appropriate.
A higher-cost episode may represent an avoidable complication. It may also reflect legitimate clinical complexity, a limited post-acute market, or a patient who required additional support to recover safely.
Leaders must be able to tell the difference.
Clinically credible information becomes essential when organizations evaluate episode performance.
The medical record should accurately describe the patient’s baseline condition, functional limitations, comorbidities, procedural risk, complications, discharge needs, and reasons for selecting a particular level of post-acute care.
Clinical Documentation Integrity has a focused role, but not simply as a method of increasing coded severity.
In an episode-based environment, documentation helps the organization interpret performance accurately. It may clarify whether resource use reflected legitimate patient needs, an unexpected clinical event, or an avoidable breakdown in the care pathway.
Documentation should not be used to explain away poor outcomes. At the same time, incomplete documentation should not allow legitimate complexity to disappear from the analysis.
This requires balanced oversight. Organizations need accurate clinical information, but they must also ensure that documentation, coding, and risk-adjustment efforts remain clinically supported and compliant.
The purpose is not to make the patient appear more complex.
The purpose is to ensure that the information used to evaluate the episode reflects the clinical reality.
Hospitals should not wait until CJR-X is finalized or until they receive a participation notice to begin developing episode-management capabilities.
The most important preparation is not a narrow implementation checklist. It is an honest assessment of whether the organization can manage care and performance across settings.
Leadership teams should be able to answer five questions.
Hospitals should know where spending occurs during and after the hospitalization, including post-acute care, rehabilitation, follow-up services, emergency department utilization, and readmissions.
Organizations should be able to differentiate patient-driven, clinically necessary, geographic, provider-related, and process-related variation.
Accountability should not end when the patient leaves the operating room or is discharged from the hospital.
Hospitals need visibility into provider availability, outcomes, communication reliability, and barriers affecting patient access.
Financial and utilization data must be interpreted alongside accurate clinical information.
These capabilities will remain valuable even if individual provisions of CJR-X change before the model is finalized.
The current CMS Innovation Center strategic direction reinforces the larger movement toward financial accountability. CMS has stated that future Innovation Center models will prioritize high-value care, incentivize reductions in unnecessary utilization, include downside financial risk, and move more Medicare and Medicaid beneficiaries into accountable-care arrangements in which providers assume financial responsibility.[4]
That does not mean every service will immediately be placed into a mandatory episode model.
It does mean hospital leaders should recognize the trajectory.
Medicare is moving from isolated services toward connected episodes.
It is moving from responsibility for the hospital encounter toward responsibility for recovery.
It is moving from voluntary experimentation toward broader financial accountability.
And it is asking hospitals to understand not only what care was delivered, but whether the entire pathway was coordinated, clinically appropriate, and financially sustainable.
The question is no longer limited to:
The more important question is:
The signals point toward hospitals that can manage beyond their own walls, understand variation without compromising clinical judgment, build stronger relationships across the care continuum, and accept accountability for both outcomes and resources.
That is not simply another regulatory requirement.
It is the emerging operating model for healthcare’s next decade.
1. Centers for Medicare & Medicaid Services. FY 2027 Hospital Inpatient Prospective Payment System Proposed Rule Home Page. CMS. Displayed April 10, 2026; published April 14, 2026.
https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/fy-2027-ipps-proposed-rule-home-page
2. Centers for Medicare & Medicaid Services Innovation Center. CJR-X: Comprehensive Care for Joint Replacement Expanded Model. CMS. Updated April 14, 2026.
https://www.cms.gov/priorities/innovation/innovation-models/cjr-x
3. Centers for Medicare & Medicaid Services Innovation Center. TEAM: Transforming Episode Accountability Model. CMS. Updated July 6, 2026.
https://www.cms.gov/priorities/innovation/innovation-models/team-model
4. Centers for Medicare & Medicaid Services Innovation Center. Strategic Direction. CMS. Originally posted May 13, 2025; updated March 16, 2026.
https://www.cms.gov/priorities/innovation/about/strategic-direction
This article was originally published on RACmonitor.
July 27, 2026
A new analysis finds that Medicare Advantage enrollees spend less on average than those in the traditional program, but report similar satisfaction levels.
This article was originally published on Fierce Healthcare.
July 24, 2026
Addressing healthcare’s biggest challenges will require payers and providers working together.
This article was originally published on Fierce Healthcare.
July 23, 2026
The ruling upheld a previous decision that pharma companies cannot impose rebates without HHS Secretary approval.
This article was originally published on Fierce Healthcare.
Author: Ronald Hirsch, MD, FACP, ACPA-C, CHCQM, CHRI | July 22, 2026
Lots of topics for today. First, last week I was discussing a hospital’s Program for Evaluating Payment Patterns Electronic Report (PEPPER) results with them and noted that they were a high outlier for one-day inpatient admissions. Their number was small, but nonetheless, they exceeded the 80th percentile. But this was not news to them, as they had just received a letter from their Medicare Administrative Contractor (MAC) informing them that they were selected for an audit of their short-stay inpatient admissions.
As you may recall, the Centers for Medicare & Medicaid Services (CMS) gave this duty back to the MACs from the Quality Improvement Organizations (QIOs) late last year, and it appears that the MACs are finally ready to start auditing. Of course, my hope is that they can interpret the Two-Midnight Rule better than they did back when these audits first started in 2014, after which CMS had to reassign the duty to the QIOs.
Speaking of the PEPPER, I am having continuing frustration with the new iteration. In light of the resumption of the short-stay audits, I took a close look at the data reported on the PEPPER to try to figure out what can be considered a normal rate of one-day inpatient admissions. Now, before you protest, I know every hospital is different, and if you get the status right on every patient, your short-stay rate is what it should be. But we all know that people like benchmarks.
And lo and behold, there was a significant problem. In the PEPPER for the fourth quarter of 2025, it states that the national 80th percentile for the last 10 quarters for one-day inpatient medical DRG admissions was about 10 percent. But in that same table, in the next PEPPER for the first quarter of 2026, that same 80th percentile for the previous 10 quarters was indicated as about 15 percent. That’s a huge difference.
And when I asked CMS, they responded that there was a “methodology refinement.” Now, I could understand an adjustment of a percentage point or two, but errors like this by the new CMS PEPPER contractor really call into question the legitimacy of all the data. Now, I wonder if it is better to have bad data than no data.
Next, Humana recently published a policy change indicating that they will start denying payments under their readmission program for patients who return and are placed as outpatient with observation, in addition to patients who are readmitted as inpatients. Now, to give them credit, they do note that they will review to determine if the return was related or preventable.
But if you start seeing such denials, I would ensure that they were reviewed per their policy. If the hospital’s processes or lack of proper discharge planning did not result in the return, why should you be forced to relinquish payment? Does Humana take the blame when one of their enrollees is readmitted because their contracted home care agency does not provide the patient the necessary home care? I think not.
Finally, let me share, without further comment, an appeal saga that a case manager experienced. “We received a denial from an MA (Medicare Advantage) plan. We consulted with the patient at the bedside, and the patient and the admitting physician signed the AOR form. We submitted all documentation to them as a Fast Appeal. When we followed up on their receipt, they stated that they received it as a Standard Appeal. We were transferred around, sometimes to the same person, and we were eventually told that the account has been reclassified as a Fast Appeal.”
She went on to note that “a few days later, we followed up again and were told that, since there is no AOR form, it is a Standard Appeal. We asked them to open the document while we were on the phone, and lo and behold, the AOR form is there.
They are now stating that we must resubmit everything again as a Fast Appeal. The patient has since been discharged, of course.”
This article was originally published on RACmonitor.
July 22, 2026
The companies say providers will receive quicker, first-time approvals through the partnership, ultimately giving members quicker care access.
This article was originally published on Fierce Healthcare.
July 22, 2026
The Trump administration will appeal a Georgia court ruling that led it to broadly recalculate insurers’ Medicare Advantage star ratings scores for 2026.
This article was originally published on Fierce Healthcare.
July 22, 2026
Cigna Healthcare is taking steps to significantly expand its personalized care management programs, leaning on AI to identify risks sooner and simplify the patient journey.
This article was originally published on Fierce Healthcare.